BriaCell Therapeutics Corp. (BCTXL) Stock Ticker
Market factors today
Unlock the full BCTXL picture
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
BCTXL stock facts
| Ticker symbol | BCTXL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $9.1M |
| CEO | William V. Williams |
| Employees | 17 |
| Headquarters | West Vancouver, BC, CA |
| IPO date | 2026-01-14 |
| Website | briacell.com |
What you can see for BCTXL on Tickr
Live BCTXL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BCTXL report.
Rankings
FAQ
What is the ticker symbol for BriaCell Therapeutics Corp.?
The ticker symbol for BriaCell Therapeutics Corp. is BCTXL, listed on the NASDAQ.
What is BCTXL?
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky…